Literature DB >> 17283337

Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.

Yeny Martinez de la Torre1, Chiara Buracchi, Elena M Borroni, Jana Dupor, Raffaella Bonecchi, Manuela Nebuloni, Fabio Pasqualini, Andrea Doni, Eleonora Lauri, Chiara Agostinis, Roberta Bulla, Donald N Cook, Bodduluri Haribabu, Pierluigi Meroni, Daniel Rukavina, Luca Vago, Francesco Tedesco, Annunciata Vecchi, Sergio A Lira, Massimo Locati, Alberto Mantovani.   

Abstract

Fetal loss in animals and humans is frequently associated with inflammatory conditions. D6 is a promiscuous chemokine receptor with decoy function, expressed in lymphatic endothelium, that recognizes and targets to degradation most inflammatory CC chemokines. Here, we report that D6 is expressed in placenta on invading extravillous trophoblasts and on the apical side of syncytiotrophoblast cells, at the very interface between maternal blood and fetus. Exposure of D6-/- pregnant mice to LPS or antiphospholipid autoantibodies results in higher levels of inflammatory CC chemokines and increased leukocyte infiltrate in placenta, causing an increased rate of fetal loss, which is prevented by blocking inflammatory chemokines. Thus, the promiscuous decoy receptor for inflammatory CC chemokines D6 plays a nonredundant role in the protection against fetal loss caused by systemic inflammation and antiphospholipid antibodies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17283337      PMCID: PMC1892950          DOI: 10.1073/pnas.0607514104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

Review 2.  The antiphospholipid syndrome.

Authors:  Jerrold S Levine; D Ware Branch; Joyce Rauch
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

Review 3.  Chemokine expression and function at the human maternal-fetal interface.

Authors:  Penelope M Drake; Kristy Red-Horse; Susan J Fisher
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

4.  Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6.

Authors:  Anna M Fra; Massimo Locati; Karel Otero; Marina Sironi; Paola Signorelli; Maria L Massardi; Marco Gobbi; Annunciata Vecchi; Silvano Sozzani; Alberto Mantovani
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

Review 5.  Tuning inflammation and immunity by chemokine sequestration: decoys and more.

Authors:  Alberto Mantovani; Raffaella Bonecchi; Massimo Locati
Journal:  Nat Rev Immunol       Date:  2006-12       Impact factor: 53.106

Review 6.  Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines.

Authors:  A Mantovani; M Locati; A Vecchi; S Sozzani; P Allavena
Journal:  Trends Immunol       Date:  2001-06       Impact factor: 16.687

7.  The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines.

Authors:  Michele Weber; Emma Blair; Clare V Simpson; Maureen O'Hara; Paul E Blackburn; Antal Rot; Gerard J Graham; Robert J B Nibbs
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

8.  Critical paracrine interactions between TNF-alpha and IL-10 regulate lipopolysaccharide-stimulated human choriodecidual cytokine and prostaglandin E2 production.

Authors:  Timothy A Sato; Jeffrey A Keelan; Murray D Mitchell
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

9.  Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.

Authors:  Raffaella Bonecchi; Massimo Locati; Emanuela Galliera; Marisa Vulcano; Marina Sironi; Anna M Fra; Marco Gobbi; Annunciata Vecchi; Silvano Sozzani; Bodduluri Haribabu; Jo Van Damme; Alberto Mantovani
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

Review 10.  Chemokine receptors: multifaceted therapeutic targets.

Authors:  Amanda E I Proudfoot
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

View more
  57 in total

Review 1.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

2.  Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues.

Authors:  Astrid E Cardona; Margaret E Sasse; Liping Liu; Sandra M Cardona; Makiko Mizutani; Carine Savarin; Taofang Hu; Richard M Ransohoff
Journal:  Blood       Date:  2008-03-17       Impact factor: 22.113

3.  Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels.

Authors:  Robert D Berahovich; Brian A Zabel; Susanna Lewén; Matthew J Walters; Karen Ebsworth; Yu Wang; Juan C Jaen; Thomas J Schall
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

Review 4.  The integrative roles of chemokines at the maternal-fetal interface in early pregnancy.

Authors:  Mei-Rong Du; Song-Cun Wang; Da-Jin Li
Journal:  Cell Mol Immunol       Date:  2014-08-11       Impact factor: 11.530

Review 5.  Neonatal effects of maternal antiphospholipid syndrome.

Authors:  Angela Tincani; Chiara Biasini Rebaioli; Laura Andreoli; Andrea Lojacono; Mario Motta
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

6.  Cutting edge: rapid accumulation of epidermal CCL27 in skin-draining lymph nodes following topical application of a contact sensitizer recruits CCR10-expressing T cells.

Authors:  Victor Huang; Anke S Lonsdorf; Lei Fang; Takashi Kakinuma; Vivian C Lee; Emily Cha; Hong Zhang; Keisuke Nagao; Marzanna Zaleska; Waldemar L Olszewski; Sam T Hwang
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 7.  Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology.

Authors:  Richard M Ransohoff
Journal:  Immunity       Date:  2009-11-20       Impact factor: 31.745

8.  Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.

Authors:  Antal Rot; Clive McKimmie; Claire L Burt; Kenneth J Pallas; Thomas Jamieson; Monika Pruenster; Richard Horuk; Robert J B Nibbs; Gerard J Graham
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

Review 9.  Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?

Authors:  Carlo Chizzolini; Jean-Michel Dayer; Pierre Miossec
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

10.  CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway.

Authors:  Julie Catusse; David J Clark; Ursula A Gompels
Journal:  J Inflamm (Lond)       Date:  2009-07-30       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.